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Acetylation of importin-α nuclear import factors by CBP/p300
Andrew J. Bannister*, Eric A. Miska*, Dirk Görlich† and Tony Kouzarides*
Histone acetylases were originally identified because of
their ability to acetylate histone substrates [1–3].
Acetylases can also target other proteins such as
transcription factors [4–7]. We asked whether the
acetylase CREB-binding protein (CBP) could acetylate
proteins not directly involved in transcription. A large
panel of proteins, involved in a variety of cellular
processes, were tested as substrates for recombinant
CBP. This screen identified two proteins involved in
nuclear import, Rch1 (human importin-α) and importin-α7,
as targets for CBP. The acetylation site within Rch1 was
mapped to a single residue, Lys22. By comparing the
context of Lys22 with the sequences of other known
substrates of CBP and the closely related acetylase
p300, we identified G/SK (in the single-letter amino
acid code) as a consensus acetylation motif.
Mutagenesis of the glycine, as well as the lysine,
severely impaired Rch1 acetylation, supporting the view
that GK is part of a recognition motif for acetylation by
CBP/p300. Using an antibody raised against an
acetylated Rch1 peptide, we show that Rch1 was
acetylated at Lys22 in vivo and that CBP or p300 could
mediate this reaction. Lys22 lies within the binding site
for a second nuclear import factor, importin-β.
Acetylation of Lys22 promoted interaction with
importin-β in vitro. Collectively, these results
demonstrate that acetylation is not unique to proteins
involved in transcription. Acetylation may regulate a
variety of biological processes, including nuclear import.
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Results and discussion
Table 1 shows that two nuclear import factors, Rch1 and
importin-α7, were acetylated by recombinant CBP, as was
the transcription factor HMG1. The fact that many pro-
teins were not acetylated by CBP in this assay testifies to
the specificity of the observed acetylation of import
factors. The acetylation of HMG1 serves as a positive
control, as it is already known to be acetylated in vivo at
Lys2 and Lys11 [8]. A negative result in this screen does
not, however, rule out the possibility that these substrates
are acetylated by CBP or another acetylase in vivo.
Rch1 is an importin-α isoform that recognises classical
nuclear localisation signals (NLSs) and functions as an
import adapter, allowing access to the importin-β-depen-
dent import pathway. There are at least six importin-α
isoforms in human [9,10]. They all comprise two func-
tional domains, an amino-terminal importin-β binding
(IBB) domain that confers binding to and import by
importin-β [11,12] and an arm-repeat domain that har-
bours the NLS-binding site (Figure 1a). The acetylase
domain of CBP acetylated Rch1 and importin-α7 at levels
comparable to the acetylation of histones (Figure 1b).
Another family member, importin-α3 was, however, not
acetylated by CBP, suggesting that acetylation may be
relevant to the function of certain importin isoforms.
Deletion analysis of Rch1 indicated that a domain com-
posed of the amino-terminal 95 residues (1–95) was suffi-
cient for acetylation by CBP, whereas a construct lacking
this region (56–529) was not a substrate (Figure 1c).
The domain of Rch1 acetylated by CBP overlaps with the
IBB domain [9]. The NLS-bound Rch1 has to interact
with the nuclear pore-associated importin-β in order for
nuclear import to take place [13,14]. We therefore asked if
the Rch1–importin-β association was affected by acetyla-
tion. We prepared in parallel two preparations of bacteri-
ally expressed Rch1: one acetylated by CBP using
14C-acetyl-CoA and the other metabolically labelled with
35S-methionine to serve as the control for binding.
Table 1
Panel of proteins tested as substrates for CBP.
Substrate Acetylated by CBP Function
HMG1 Yes Transcription factor
Rch1 Yes Nuclear import
Importin-α7 Yes Nuclear import
Importin-α3 No Nuclear import
TRF1 No Chromosome structure
TRF2 No Chromosome structure
RPA No Nuclear excision repair
HHR23B No Nuclear excision repair
hENDO1 No DS break repair
hAPendo1 No DS break repair
Ku70/80 No DS break repair
PRP2 No RNA splicing
Approximately 0.5–1 µg of each recombinant protein was incubated
with glutathione-S-transferase (GST)–CBP (residues 1098–1758) and
14C-acetyl-CoA in a standard histone acetyltransferase reaction [17].
DS, double-stranded. 
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Equimolar amounts of each Rch1 preparation were then
used in importin-β binding assays and the relative binding
to importin-β was determined for each preparation
(Figure 1d). We found that the CBP-dependent acetylation
of Rch1 increased its ability to bind importin-β by approx-
imately 3–4-fold, suggesting that the acetylation of Rch1
seen here in vitro could regulate nuclear import.
To establish whether the acetylated lysine residue falls
within the importin-β binding interface, we carried out a
further deletion analysis. Figure 2a shows that this is the
case. Crucially, residues 23–82 were not acetylated by
CBP but when an additional six residues were included
amino-terminally (17–82), acetylation was observed. This
indicates that the motif FKNKGK can confer acetylation
to Rch1. Protein sequence analysis of CBP-acetylated
Rch1 confirmed that the acetylation site maps to this
motif and involves only Lys22 (Figure 2b). This mapping
places the acetylated lysine at the interface between
Rch1 and importin-β. Recently, the crystal structure of an
Rch1 domain bound to importin-β has been reported [15].
The structure indicates that Lys22 is an unusual basic
residue within the IBB domain because it does not form a
stabilising salt bridge with any acidic residues from
importin-β unlike the nearby residues Lys18 and Lys20.
Thus, neutralisation of the basic charge of Lys22 by
acetylation would not be predicted to be detrimental to
the interaction. Perhaps the observed stabilisation of the
interaction (Figure 1d) comes about because acetylation
of Lys22 repositions its neighbours into a more favourable
binding conformation.
Having established Lys22 as the site for acetylation in Rch1,
we asked whether the context of this lysine is conserved
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Figure 1
Identification of substrates for the CBP acetylase. (a) Schematic
representation of Rch1 and deletion constructs. (b) Rch1 and
importin-α7 but not importin-α3 are acetylated by CBP. Approximately
1 µg of each protein was incubated with GST–CBP (residues
1098–1758) and 14C-acetyl-CoA in a standard HAT reaction [18].
Reaction products were resolved by SDS–PAGE and viewed following
autoradiography. Histones serve as a positive control. There was no
detectable radiolabelling of substrate when CBP was omitted (data not
shown). (c) CBP acetylates Rch1 within its amino terminus. The
indicated Rch1 regions were tested as substrates of CBP. Reactions
were performed as in (b). (d) Acetylation of Rch1 increases its binding
to importin-β. Two preparations of bacterially expressed His-tagged
Rch1 were prepared in parallel. One was metabolically labelled in
Escherichia coli using 35S-methionine, purified using Ni2+–agarose,
eluted from the beads and then mock-acetylated, thereby serving as
the control for binding. The other was prepared identically except that
it was not labelled with 35S-methionine but was radioactively
acetylated by CBP using 14C-acetyl-CoA. Z-tagged importin-β was
also expressed in, and purified from, bacteria and was left attached to
immunoglobulin G–agarose beads. A binding reaction (binding buffer:
50 mM Tris.Cl pH 7.5, 500 mM NaCl, 5 mM magnesium acetate,
10 mM β-mercaptoethanol) was then set up containing excess
agarose-bound importin-β and an equimolar amount of either
35S-labelled Rch1 or 14C-acetylated Rch1. Reactants were slowly
rotated at room temperature for 2 h. The reactions were then pelleted,
washed extensively with binding buffer, resolved by SDS–PAGE and
blotted. The relative binding to importin-β was determined for each
preparation of Rch1 using a PhosphorImager. The results of two
independent experiments are presented.
Figure 2
Lys22 of Rch1 is acetylated by CBP. (a) Rch1 residues 17–22 are
crucial for acetylation by CBP. The indicated Rch1 deletions (see
Figure 1a) were tested as substrates of CBP. Reactions were performed
as described in Figure 1b and the resulting autoradiogram is shown.
(b) CBP acetylates Rch1 residue Lys22. A peptide fragment of Rch1
corresponding to amino acids 10–82 was 14C-acetylated by CBP using
standard conditions [18]. The reaction products were resolved by
SDS–PAGE and blotted to PVDF membrane. Automated Edman
degradation was performed on the blotted material and each cycle
fraction was collected and counted using a liquid scintillation counter. 
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relative to CBP-acetylated lysines in other proteins. An
alignment of other known CBP targets (Figure 3a) indi-
cates that the only detectable preference is a glycine or
serine residue directly preceding the acetylated lysine.
The exception is p53, which has a lysine at this position
and one of the sites in histone H4 that has an alanine.
To assess the importance of the conserved GK sequence
in Rch1, we carried out a mutagenic analysis. Mutating
Gly21 severely disrupted acetylation by CBP; the severity
of this mutation was comparable to mutating the acety-
lated lysine, Lys22 (Figure 3b). In contrast, mutating
Lys18 and Lys20 had little or no effect. Essentially identi-
cal results were obtained using p300 (data not shown).
The importance of the GK sequence for CBP/p300 acety-
lation is consistent with the finding that importin-α3,
which does not have a GK sequence, was not acetylated
by CBP (Figure 1b). Moreover, these results are consis-
tent with the recently reported crystal structure of the
Tetrahymena GCN5 acetylase bound to a histone H3
peptide, which indicates that a glycine residue immedi-
ately preceding the acetylated lysine within H3 is impor-
tant for recognition by the acetylase [16]. These results
indicate that residues other than lysines are necessary as a
recognition site for a mammalian acetylase. We suspect
that other determinants, less obvious than the glycine or
serine residue, may also be necessary to determine the
specificity, because some of the proteins that are not
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Figure 3
The GK motif is required for efficient
acetylation of Rch1 by CBP. (a) Alignment of
known CBP acetylation sites within different
substrates. The GK motif (see text) is shown
in red. The lysine residues shown in red are
known to be acetylated in vivo (HMG1 [8],
histone H4 [19], GATA-1 [5], HMG(I)Y [7]
and p53 [4]) and/or by CBP in vitro (Rch1
(this study), histone H4 [20], GATA-1 [5],
TFIIE [21], HMG(I)Y [7] and p53 [4]).
(b) Schematic representation of Rch1
indicating the wild-type (WT) protein sequence
(amino acids 17–22). The wild-type (WT)
protein sequence (amino acids 17–22) and
the positions and sequence of the mutations
introduced into Rch1 are shown below. A
dash indicates no change. Rch1 17–82
(or the indicated mutant) was used as
substrate for CBP essentially as described for
Figure 1, except that following SDS–PAGE
the Rch1 band was excised and the amount
of acetylation determined by liquid scintillation
counting. The amount of acetylation is given
relative to that of wild-type Rch1. These data
are expressed graphically on the right.
Figure 4
Rch1 is acetylated by p300 at Lys22 in vivo.
(a) Western blot showing Rch1 acetylation
in vivo. U2OS cells were transiently
transfected with an expression vector driving
the expression of full-length Rch1 with carboxy-
terminal Myc and His6 tags. An expression
vector encoding p300 was co-transfected as
indicated. After washing off the DNA
precipitate, the cells were allowed to recover
for 12 h before TSA was added as indicated.
Partial purification of the Rch1 protein was
then performed using Ni2+–agarose. The
Rch1 was resolved by SDS–PAGE, blotted
and probed with the AcK22 antibody. The blot
was then stripped and re-probed with an anti-
Myc antibody, which confirmed equal amounts
of Rch1 in each lane (data not shown). No
signal was detected when non-transfected
cells treated with TSA were used (data not
shown). (b) Peptide competition confirms that
Rch1 is acetylated at Lys22 in vivo. Rch1 and
p300 were transfected into U2OS cells. The
cells were then exposed to TSA, the Rch1
protein purified as in (a) and then western
blotted. Equal amounts of the same extract
were loaded in each lane. The blot was
probed with antibody AcK22 in the presence
or absence of 1 µg/ml competitor peptide as
indicated. The arrow in (a,b) indicates the
position of Rch1–His6. The antibody was
raised against Rch1 16-RFKNKGK*DSTEM-
27, where K* indicates the acetylated lysine.
The unacetylated peptide was identical
except there was no acetyl group at Lys22.
(c) Endogenous Rch1 is acetylated in vivo.
293T cells were either mock-transfected (–)
or transfected with an expression vector
encoding p300 (+). Cells were either treated
or not treated with TSA as in (a). Total
cellular extract was prepared and resolved
by SDS–PAGE, blotted and probed with
AcK22 (lanes 1–4) or a control anti-Rch1
antibody (lane 5). The asterisk indicates the
position of Rch1.
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substrates for CBP in Table 1 do contain G/SK residues.
Nevertheless, the G/SK sequence can serve as a guide for
potential CBP/p300 acetylation sites once a protein is
demonstrated to be a CBP/p300 target. 
We next asked whether Rch1 was acetylated at the GK
motif in vivo. In order to do this, we raised a rabbit poly-
clonal antibody (AcK22) that specifically recognises acety-
lated Rch1 (Figure 4). To test the specificity of the AcK22
antibody we first transfected a carboxy-terminally His-
tagged version of Rch1 into cells and, following purification,
we western blotted with AcK22. The antibody recognized
Rch1 efficiently when a deacetylase inhibitor, TSA, was
included (Figure 4a, compare lanes 1 and 2). Introduction of
exogenous p300 into cells increased dramatically the recog-
nition of acetylated Rch1 by AcK22 (lane 3). These results
confirm that AcK22 recognises acetylated Rch1 in vivo. To
confirm that the acetylation on Rch1 occurred at the GK
motif, we used a peptide competition assay. Figure 4b
shows that recognition of acetylated Rch1 by the AcK22
antibody was not inhibited by a peptide containing an
unacetylated GK motif (Figure 4b, compare lanes 1 and 2).
When the peptide was acetylated specifically at Lys22,
however, it could effectively compete for the recognition of
Rch1 by the AcK22 antibody. In contrast, an acetylated
control peptide derived from the transcription factor E2F1
(which is known to be acetylated in vivo, [17]) did not
compete for the recognition of acetylated Rch1. These
results therefore show that the AcK22 antibody recognises
specifically the acetylated version of Rch1 and that this
recognition is context-dependent, that is, it recognises
acetylated Lys22 only in the context of Rch1. We can there-
fore conclude that Rch1 can be acetylated in vivo by p300
and that this acetylation takes place at Lys22.
Finally, we asked whether the AcK22 antibody could
detect endogenous acetylated Rch1 in a total cellular
extract in which Rch1 had not been overexpressed
(Figure 4c). AcK22 weakly recognized a band (lane 1,
asterisk) that comigrated with Rch1 (lane 5). The other
proteins recognized by the AcK22 antibody in lane 1 may
correspond to importin-α isoforms. Significantly, the aster-
isked band in lane 1 has the characteristics of acetylated
Rch1, as determined for transfected Rch1 in Figure 4a.
Thus, detection of endogenously acetylated Rch1 was
augmented slightly by the addition of TSA or by p300
transfection (lanes 2 and 3) and synergistically when both
TSA and p300 were present (lane 4). These observations,
plus the characterised specificity of AcK22 (Figure 4b),
confirm that endogenous Rch1 is acetylated. However, the
acetylated form could be detected only when the balance
was biased towards the acetylated state. This is presum-
ably because Rch1 acetylation is tightly controlled in vivo.
Our results point to the possibility that nuclear import
may be subject to regulation by acetylation. Acetylation of
Rch1 by CBP/p300 is likely to take place in the nucleus
where CBP/p300 are localised, but may also affect the
function of Rch1 when it shuttles to the cytoplasm. How
acetylation regulates nuclear import functions remains to
be established, but the results presented here suggest that
acetylation may not necessarily be confined to the regula-
tion of transcription, but may well affect other cellular
processes, such as nuclear import.
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